Raelene Murphy Purchases 15,000 Shares of Integral Diagnostics Limited (ASX:IDX) Stock

Integral Diagnostics Limited (ASX:IDX) insider Raelene Murphy bought 15,000 shares of Integral Diagnostics stock in a transaction that occurred on Tuesday, March 11th. The shares were acquired at an average cost of A$2.36 ($1.50) per share, with a total value of A$35,400.00 ($22,547.77).

Integral Diagnostics Price Performance

The company has a current ratio of 0.86, a quick ratio of 1.84 and a debt-to-equity ratio of 118.59. The firm has a market cap of $1.10 billion, a price-to-earnings ratio of -11.45, a price-to-earnings-growth ratio of 1.39 and a beta of 0.73.

Integral Diagnostics Announces Dividend

The company also recently disclosed a Interim dividend, which will be paid on Sunday, April 6th. Shareholders of record on Sunday, April 6th will be issued a $0.025 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a yield of 1.06%. Integral Diagnostics’s payout ratio is -23.08%.

Integral Diagnostics Company Profile

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.